{"title":"Whole-Genome Sequencing Reveals the Evolutionary Characterization of Bovine Coronavirus","authors":"Shanshan Qi, Ying Yang, Junwen Deng, Xinxian Wang, Yangxi Li, Jiaxing Sun, Qian Li, Shurui Yang, Gefen Yin, Yongneng Li, Junlong Bi","doi":"10.1155/tbed/5152361","DOIUrl":null,"url":null,"abstract":"<div>\n <p>Bovine coronavirus (BCoV) is endemic worldwide, causing gastrointestinal and respiratory diseases in cattle, making it a topic of significant interest. The present study investigated the prevalence and evolutionary characterization of BCoV identified in Yunnan, China. The results indicated that the overall seroprevalence was 21.75% (65/285), with a higher rate (25.56%) in diarrhea samples than in healthy samples (15.24%). Meanwhile, PCR was used to detect BCoV pathogens in 616 fecal samples. The overall BCoVs positive rate in Yunnan was 28.73% (177/616), with diarrhea samples showing a higher rate (37.46%) compared to healthy samples (20.50%). The whole genomes of three BCoV strain were successfully amplified, namely, BCoV/YN1LC/2023, BCoV/YNZT/2023, and BCoV/YNLP/2023. These identified strains showed high homology to strains derived from calf diarrhea and respiratory samples than to the classical and vaccine strains. Sequence analyses revealed that seven consistent amino acid mutations in the S protein of three BCoV identified strains, including M<sup>11</sup>/T, K<sup>115</sup>/D, N<sup>146</sup>/I, D<sup>148</sup>/G, L<sup>154</sup>/F, N<sup>499</sup>/S, and N<sup>509</sup>/H. Additionally, mutations L<sup>5</sup>/P, N<sup>49</sup>/T, and L<sup>392</sup>/I were observed in the HE protein, and mutations L<sup>53</sup>/Q, M<sup>386</sup>/T, M<sup>387</sup>/I, S<sup>423</sup>/I, and Y<sup>441</sup>/F were found in the N protein. Identified as a recombinant strain, the BCoV/YNLP/2023 displays a unique mutation S<sup>501</sup>/F in the S protein, D<sup>66</sup>/G in the HE protein, and the <sup>206</sup>SRA<sup>208</sup> deletion in the N protein. Phylogenetic analysis suggested that the identified strains could be the predominant strains in Yunnan Province or even in Southwest China, demonstrating geographic clustering. These data highlight BCoV’s high prevalence and evolutionary characterization in Yunnan, China, providing valuable information for the effective prevention and control of BCoV in the future.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/5152361","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/5152361","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Bovine coronavirus (BCoV) is endemic worldwide, causing gastrointestinal and respiratory diseases in cattle, making it a topic of significant interest. The present study investigated the prevalence and evolutionary characterization of BCoV identified in Yunnan, China. The results indicated that the overall seroprevalence was 21.75% (65/285), with a higher rate (25.56%) in diarrhea samples than in healthy samples (15.24%). Meanwhile, PCR was used to detect BCoV pathogens in 616 fecal samples. The overall BCoVs positive rate in Yunnan was 28.73% (177/616), with diarrhea samples showing a higher rate (37.46%) compared to healthy samples (20.50%). The whole genomes of three BCoV strain were successfully amplified, namely, BCoV/YN1LC/2023, BCoV/YNZT/2023, and BCoV/YNLP/2023. These identified strains showed high homology to strains derived from calf diarrhea and respiratory samples than to the classical and vaccine strains. Sequence analyses revealed that seven consistent amino acid mutations in the S protein of three BCoV identified strains, including M11/T, K115/D, N146/I, D148/G, L154/F, N499/S, and N509/H. Additionally, mutations L5/P, N49/T, and L392/I were observed in the HE protein, and mutations L53/Q, M386/T, M387/I, S423/I, and Y441/F were found in the N protein. Identified as a recombinant strain, the BCoV/YNLP/2023 displays a unique mutation S501/F in the S protein, D66/G in the HE protein, and the 206SRA208 deletion in the N protein. Phylogenetic analysis suggested that the identified strains could be the predominant strains in Yunnan Province or even in Southwest China, demonstrating geographic clustering. These data highlight BCoV’s high prevalence and evolutionary characterization in Yunnan, China, providing valuable information for the effective prevention and control of BCoV in the future.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.